The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking ...

Cost Plus Drugs is sharing pricing data with TrumpRx, the administration’s new direct-to-consumer prescription drug website ...

President Donald Trump is working on a deal with major pharmaceutical companies, including Pfizer, to lower the cost of ...

Consumers have one major defense against rising costs, shrinking provider networks and disappearing benefits: Medicare’s fall ...

The U.S. Congressional Budget Office said on Monday that new exemptions to drug price negotiations for several blockbuster ...

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...

In Minnesota, the second-largest Medicare Advantage health insurer — Minneapolis-based UCare — announced it was exiting the ...

Medicare beneficiaries face higher costs, reduced services, and possible cuts to the program at large—but there’s good news ...

The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

Seniors can switch between Original Medicare and Medicare Advantage, or change Part D drug coverage. Plans change ...